Processa Pharmaceuticals (PCSA) Shares Issued (2018 - 2026)
Processa Pharmaceuticals' (PCSA) quarterly Shares Issued came in at $136372.0 in Q1 2026, down 61.63% YoY from $355415.0 in Q1 2025, and little changed on a QoQ basis from $136372.0 in Q4 2025.
Processa Pharmaceuticals (PCSA) Shares Issued (2018 - 2026) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 9 years of Shares Issued data on file, last reported at $136372.0 in Q1 2026.
- Quarterly Shares Issued fell 61.63% year-over-year to $136372.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136372.0 (down 61.63% YoY) and the FY2025 annual result came in at $136372.0, up 121660.71% from the prior year.
- Shares Issued steadied at $136372.0 in Q1 2026, from $136372.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $10.4 million in Q3 2025 to a low of $112.0 in Q4 2024.
- A 5-year average of $1.3 million and a median of $141611.0 in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued sank 98.06% — and 2025, when it surged 121660.71%.
- Tracing PCSA's Shares Issued over 5 years: stood at $8943.0 in 2022, then tumbled by 96.62% to $302.0 in 2023, then tumbled by 62.91% to $112.0 in 2024, then surged by 121660.71% to $136372.0 in 2025, then changed by 0.0% to $136372.0 in 2026.
- The last three Shares Issued figures came in at $136372.0 (Q1 2026), $136372.0 (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - | 136,372.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 136,372.00 |
| Mar 31, 2026 | 136,372.00 |
| Dec 31, 2025 | 136,372.00 |
| Dec 31, 2025 | 136,372.00 |
| Sep 30, 2025 | 10.36 Mn |
| Sep 30, 2025 | 10.36 Mn |
| Jun 30, 2025 | 2,747.00 |
| Jun 30, 2025 | 2,747.00 |
| Mar 31, 2025 | 355,415.00 |
| Mar 31, 2025 | 355,415.00 |
| Dec 31, 2024 | 112.00 |
| Dec 31, 2024 | 112.00 |
| Sep 30, 2024 | 353,641.00 |
| Sep 30, 2024 | 353,641.00 |
| Jun 30, 2024 | 2,747.00 |
| Jun 30, 2024 | 2,747.00 |
| Mar 31, 2024 | 35,508.00 |
| Mar 31, 2024 | 35,508.00 |
| Dec 31, 2023 | 302.00 |
| Dec 31, 2023 | 302.00 |